ابحث واعثر على CMO / CDMO الذي تحتاجه

الأسواق: EMA (EU), FDA (USA)

خدمات: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

منطقة: أوروبا

امتثال: FDA (cGMP), ISO, IFS, EMA (EU GMP)

حجم الدفعة: Large, Small, Medium

الفئة / المنتج: مستحضرات التجميل, المغذيات, FDF / المنتجات الدوائية

يستخدم: Human, Veterinary

OEB (نطاقات التعرض المهني): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

OEB (نطاقات التعرض المهني): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

الأسواق: EMA (EU), ANVISA (Brazil), Russian Health Authorities, SFDA (Saudi Arabia)

منطقة: أوروبا

امتثال: ISO, Roszdravnadzor (Russia GMP), SFDA (Saudi Food & Drug Authority), EMA (EU GMP)

حجم الدفعة: Large, Small, Medium

الفئة / المنتج: مستحضرات التجميل, FDF / المنتجات الدوائية

يستخدم: Human, Veterinary

خدمات: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

منطقة: أوروبا

المواد الخاضعة للرقابة: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

الأسواق: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), MHRA (UK)

منطقة: أوروبا

امتثال: FDA (cGMP), ISO, EMA (EU GMP)

حجم الدفعة: Large, Small, Medium

يستخدم: Human, Veterinary

خدمات: Development services, Manufacturing services, Analytical / QC services

مجالات الخبرة العلاجية (ATC): (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (N) Nervous system

OEB (نطاقات التعرض المهني): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

الفئة / المنتج: FDF / المنتجات الدوائية

الأسواق: EMA (EU), FDA (USA)

منطقة: أوروبا

امتثال: FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)

حجم الدفعة: Large, Small, Medium

الفئة / المنتج: المغذيات, خدمات, هندسة الجسيمات

يستخدم: Human, Veterinary

BSL (مستوى السلامة البيولوجية): 1, 2

خدمات: Development services, Manufacturing services

OEB (نطاقات التعرض المهني): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

المواد الخاضعة للرقابة: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

الأسواق: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), Russian Health Authorities, MHRA (UK), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, TGA (Australia)

منطقة: أوروبا

حجم الدفعة: Large, Small, Medium

يستخدم: Human

خدمات: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

مجالات الخبرة العلاجية (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (A) Digestive tract and metabolism

امتثال: PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TGA (Australia GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), EMA (EU GMP), Health Canada (Canada GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

OEB (نطاقات التعرض المهني): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

الفئة / المنتج: خدمات, FDF / المنتجات الدوائية

مجالات الخبرة العلاجية (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (A) Digestive tract and metabolism

الأسواق: EMA (EU), NMPA (China), ANVISA (Brazil), Russian Health Authorities, SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities

منطقة: أوروبا

حجم الدفعة: Large

يستخدم: Human

BSL (مستوى السلامة البيولوجية): 1

خدمات: Manufacturing services, Analytical / QC services, Regulatory services, Packaging

المواد الخاضعة للرقابة: Lowest potential for abuse

امتثال: ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), NMPA (China GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)

الفئة / المنتج: FDF / المنتجات الدوائية

OEB (نطاقات التعرض المهني): 1 / low-hazard (PDE > 10,000 µg/day)

المواد الخاضعة للرقابة: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

الأسواق: EMA (EU), PMDA (Japan), NMPA (China), MHRA (UK), MFDS (South Korea)

خدمات: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

منطقة: أوروبا

حجم الدفعة: Large, Small, Medium

يستخدم: Human, Veterinary

OEB (نطاقات التعرض المهني): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

امتثال: EMA (EU GMP)

الفئة / المنتج: FDF / المنتجات الدوائية

المواد الخاضعة للرقابة: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

الأسواق: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), ANVISA (Brazil), MHRA (UK), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), TGA (Australia)

خدمات: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

منطقة: أوروبا

امتثال: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), TGA (Australia GMP), TITCK (Turkish Health Authorities), UAE Ministry of Health & Prevention, NMPA (China GMP), EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP), NSF

حجم الدفعة: Large, Small, Medium

يستخدم: Human

مجالات الخبرة العلاجية (ATC): (D) Dermatologicals, (V06) Nutrients, (A) Digestive tract and metabolism

OEB (نطاقات التعرض المهني): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

الفئة / المنتج: FDF / المنتجات الدوائية

OEB (نطاقات التعرض المهني): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

المواد الخاضعة للرقابة: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

الأسواق: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), ANMAT (Argentina), SFDA (Saudi Arabia), MFDS (South Korea), EDE (UAE), CDSCO (India), TGA (Australia)

خدمات: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

منطقة: أوروبا

امتثال: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), UAE Ministry of Health & Prevention, NMPA (China GMP), EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP), NSF

حجم الدفعة: Large, Small, Medium

يستخدم: Human

الفئة / المنتج: خدمات, FDF / المنتجات الدوائية

المواد الخاضعة للرقابة: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

الأسواق: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), MHRA (UK), SFDA (Saudi Arabia), MFDS (South Korea), EDE (UAE), CDSCO (India), TGA (Australia)

خدمات: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

منطقة: منطقة آسيا والمحيط الهادئ

امتثال: FDA (cGMP), PMDA/MHLW (Japan GMP), EMA (EU GMP)

حجم الدفعة: Large

يستخدم: Human

OEB (نطاقات التعرض المهني): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

الفئة / المنتج: خدمات, FDF / المنتجات الدوائية

الأسواق: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), MHRA (UK), MFDS (South Korea)

خدمات: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

منطقة: أوروبا

امتثال: FDA (cGMP), EMA (EU GMP)

يستخدم: Human

المواد الخاضعة للرقابة: High potential for abuse & no medical use

حجم الدفعة: Small, Medium

OEB (نطاقات التعرض المهني): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

الفئة / المنتج: FDF / المنتجات الدوائية